Sunshine Heart plans to sell its common stock through public offering

Deal has greenshoe; proceeds fund debt repayment, corporate purposes

By Devika Patel

Knoxville, Tenn., July 17 - Sunshine Heart Inc. will price a public offering of common stock, according to a Form S-1 filed Tuesday with the Securities and Exchange Commission. There will be a greenshoe option.

Canaccord Genuity is the bookrunning manager and Lazard Capital Markets, Cowen and Co., Craig-Hallum Capital Group and Northland Capital Markets are co-managers.

Proceeds will be used to repay debt, for clinical trials and general corporate purposes.

The company's stock (Nasdaq: SSH) closed at $11.03 per share on July 16.

Based in St. Leonards, Australia, Sunshine Heart produces the C-Pulse, a mechanical heart assistance device.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.